The market for over-the-counter (OTC) pharma products has developed rapidly in recent years. The ALPLA Group’s pharma packaging division ALPLApharma is responding to this by expanding its manufacturing technology for OTC bottles with the addition of flexible extrusion blow molding (EBM), which makes sustainable and customer-specific packaging solutions possible in this area.   

Following a strong growth phase, demand for over-the-counter pharmaceuticals and food supplements has been very volatile over the past two years.

There was also a decline in the sale of, for example, cold and flu remedies as a result of the coronavirus pandemic and the global measures implemented to contain it (contact restrictions, mandatory face coverings, reduced mobility).

ALPLApharma expands production capacity of OTC bottles with extrusion blow molding technology.

At the same time, vitamins and drugs that boost immune defence enjoyed a sharp upswing. The market for OTC products is forecast to remain on the growth path seen in recent years, but with the sales channels increasingly shifting in the direction of mail order business. SME vendors are also entering the market with new and innovative products.

ALPLApharma has recognized this market potential and is expanding its OTC container production capacities. In addition to the injection blow molding (IBM) technology the company has been using until now, it will henceforth also offer its customers EBM technology in its production activities.

All the advantages that the EBM procedure offers will also be applied to OTC container production. For example, EBM technology allows the thickness of the container walls to be adapted to the type and consistency of the contents. It allows the sealing surface at the neck opening to be increased, thus also increasing leak tightness.

There is additionally the option of combining different thin-walled layers with product-specific oxygen barriers.

The company also provides caps for its OTC bottles.

"Overall, EBM affords the customers the flexibility to work with us to identify just the right OTC packaging for their product and requirements – all usually in a continuous improvement process involving a single mold. The throughput times are also faster, which results in greater output," explained Andreas Lorenz, Technical Account Manager at ALPLA.

ALPLApharma also offers caps for its OTC bottles. These include CRC justONE, a unique, childproof screw cap with a tamper-evident band that is efficiently manufactured in a single injection molding process and then directly assembled.

The market for over-the-counter (OTC) pharma products has developed rapidly in recent years. The ALPLA Group’s pharma packaging division ALPLApharma is responding to this by expanding its manufacturing technology for OTC bottles with the addition of flexible extrusion blow molding (EBM), which makes sustainable and customer-specific packaging solutions possible in this area.   

Following a strong growth phase, demand for over-the-counter pharmaceuticals and food supplements has been very volatile over the past two years.

There was also a decline in the sale of, for example, cold and flu remedies as a result of the coronavirus pandemic and the global measures implemented to contain it (contact restrictions, mandatory face coverings, reduced mobility).

ALPLApharma expands production capacity of OTC bottles with extrusion blow molding technology.

At the same time, vitamins and drugs that boost immune defence enjoyed a sharp upswing. The market for OTC products is forecast to remain on the growth path seen in recent years, but with the sales channels increasingly shifting in the direction of mail order business. SME vendors are also entering the market with new and innovative products.

ALPLApharma has recognized this market potential and is expanding its OTC container production capacities. In addition to the injection blow molding (IBM) technology the company has been using until now, it will henceforth also offer its customers EBM technology in its production activities.

All the advantages that the EBM procedure offers will also be applied to OTC container production. For example, EBM technology allows the thickness of the container walls to be adapted to the type and consistency of the contents. It allows the sealing surface at the neck opening to be increased, thus also increasing leak tightness.

There is additionally the option of combining different thin-walled layers with product-specific oxygen barriers.

The company also provides caps for its OTC bottles.

"Overall, EBM affords the customers the flexibility to work with us to identify just the right OTC packaging for their product and requirements – all usually in a continuous improvement process involving a single mold. The throughput times are also faster, which results in greater output," explained Andreas Lorenz, Technical Account Manager at ALPLA.

ALPLApharma also offers caps for its OTC bottles. These include CRC justONE, a unique, childproof screw cap with a tamper-evident band that is efficiently manufactured in a single injection molding process and then directly assembled.